Qiagen NV (QGEN)
41.56
+0.48
(+1.18%)
USD |
NYSE |
Apr 26, 15:29
Qiagen Total Assets (Quarterly): 6.115B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.115B |
September 30, 2023 | 5.907B |
June 30, 2023 | 6.347B |
March 31, 2023 | 6.279B |
December 31, 2022 | 6.288B |
September 30, 2022 | 6.517B |
June 30, 2022 | 6.154B |
March 31, 2022 | 6.184B |
December 31, 2021 | 6.147B |
September 30, 2021 | 6.043B |
June 30, 2021 | 5.907B |
March 31, 2021 | 5.763B |
December 31, 2020 | 5.870B |
September 30, 2020 | 5.771B |
June 30, 2020 | 5.295B |
March 31, 2020 | 5.181B |
December 31, 2019 | 5.236B |
September 30, 2019 | 5.143B |
June 30, 2019 | 5.383B |
March 31, 2019 | 5.420B |
December 31, 2018 | 5.748B |
September 30, 2018 | 5.299B |
June 30, 2018 | 5.309B |
March 31, 2018 | 5.105B |
December 31, 2017 | 5.039B |
Date | Value |
---|---|
September 30, 2017 | 5.097B |
June 30, 2017 | 4.556B |
March 31, 2017 | 4.068B |
December 31, 2016 | 4.308B |
September 30, 2016 | 4.328B |
June 30, 2016 | 4.119B |
March 31, 2016 | 4.120B |
December 31, 2015 | 4.179B |
September 30, 2015 | 4.159B |
June 30, 2015 | 4.131B |
March 31, 2015 | 4.170B |
December 31, 2014 | 4.454B |
September 30, 2014 | 4.461B |
June 30, 2014 | 4.564B |
March 31, 2014 | 4.487B |
December 31, 2013 | 4.088B |
September 30, 2013 | 4.055B |
June 30, 2013 | 3.976B |
March 31, 2013 | 4.034B |
December 31, 2012 | 4.088B |
September 30, 2012 | 3.956B |
June 30, 2012 | 3.877B |
March 31, 2012 | 3.798B |
December 31, 2011 | 3.730B |
September 30, 2011 | 3.948B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.143B
Minimum
Sep 2019
6.517B
Maximum
Sep 2022
5.870B
Average
5.907B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
MoonLake Immunotherapeutics | 526.54M |
LENZ Therapeutics Inc | -- |
Thermo Fisher Scientific Inc | 98.73B |
uniQure NV | 831.69M |
ProQR Therapeutics NV | 152.42M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.307B |
Shareholders Equity (Quarterly) | 3.808B |
Debt to Equity Ratio | 0.3965 |
Current Ratio | 1.990 |
Net Debt Paydown Yield | 1.57% |